CpG oligodeoxynucleotides enhance host defense during murine tuberculosis

被引:83
作者
Juffermans, NP
Leemans, JC
Florquin, S
Verbon, A
Kolk, AH
Speelman, P
van Deventer, SJH
van der Poll, T
机构
[1] Univ Amsterdam, Acad Med Ctr, Lab Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
[4] Royal Trop Inst, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1128/IAI.70.1.147-152.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs activate immune cells to produce cytokines. CpG ODNs protect mice against infections with intracellular bacteria by the induction of a T helper 1 (Th1) response. To determine the effect of CpG ODNs in pulmonary tuberculosis, mice were treated with CpG ODNs or control ODNs at the time of intranasal infection. CpG ODNs reduced mycobacterial outgrowth for up to 5 weeks after Mycobacterium tuberculosis infection and were associated with a decrease in inflammation in lung tissue. CpG treatment was also associated with elevated levels of gamma interferon (IFN-gamma) and decreased levels of interleukin 4 in the lungs and an increased capacity of splenocytes to secrete Th1-type cytokines. CpG ODNs given 2 weeks after infection were still able to reduce mycobacterial outgrowth and to enhance a Th1 response 5 weeks postinfection. Administration of CpG ODNs to IFN-gamma -gene-deficient mice failed to reduce mycobacterial outgrowth. These data suggest that CpG ODNs improve host defense during pulmonary tuberculosis by an IFN-gamma -dependent mechanism.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 36 条
[1]   CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms [J].
Askew, D ;
Chu, RS ;
Krieg, AM ;
Harding, CV .
JOURNAL OF IMMUNOLOGY, 2000, 165 (12) :6889-6895
[2]  
Ballas ZK, 1996, J IMMUNOL, V157, P1840
[3]  
Bean AGD, 1999, J IMMUNOL, V162, P3504
[4]   CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity [J].
Chu, RS ;
Targoni, OS ;
Krieg, AM ;
Lehmann, PV ;
Harding, CV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1623-1631
[5]   Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol [J].
Condos, R ;
Rom, WN ;
Schluger, NW .
LANCET, 1997, 349 (9064) :1513-1515
[6]   DISSEMINATED TUBERCULOSIS IN INTERFERON-GAMMA GENE-DISRUPTED MICE [J].
COOPER, AM ;
DALTON, DK ;
STEWART, TA ;
GRIFFIN, JP ;
RUSSELL, DG ;
ORME, IM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2243-2247
[7]   Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis [J].
Cooper, AM ;
Magram, J ;
Ferrante, J ;
Orme, IM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :39-45
[8]  
Cowdery J, 1996, J IMMUNOL, V156, P4570
[9]  
Davis HL, 1998, J IMMUNOL, V160, P870
[10]   Global burden of tuberculosis - Estimated incidence, prevalence, and mortality by country [J].
Dye, C ;
Scheele, S ;
Dolin, P ;
Pathania, V ;
Raviglione, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :677-686